Skip to content
October 23, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
  • Home
  • Breast Cancer Surgery and Reconstruction
  • A New Era for Plastic Surgery: Dr. Lynn A. Damitz Takes the Helm at the American Society of Plastic Surgeons
  • Breast Cancer Surgery and Reconstruction

A New Era for Plastic Surgery: Dr. Lynn A. Damitz Takes the Helm at the American Society of Plastic Surgeons

Jia Lissa October 23, 2026 8 minutes read
a-new-era-for-plastic-surgery-dr-lynn-a-damitz-takes-the-helm-at-the-american-society-of-plastic-surgeons

HOUSTON – In a significant transition for the global medical community, Lynn A. Damitz, MD, FACS, has officially ascended to the presidency of the American Society of Plastic Surgeons (ASPS). The appointment was formalized during "Plastic Surgery The Meeting," the Society’s premier annual scientific assembly held this year in Houston. As the head of the world’s largest organization of board-certified plastic surgeons, Dr. Damitz assumes a critical leadership role that will shape the trajectory of the specialty through September 19, 2027.

Her appointment arrives at a pivotal time for the medical field, as plastic surgery faces an evolving landscape defined by rapid technological advancements, shifting healthcare policies, and an increasing public demand for both aesthetic refinement and complex reconstructive care.


The Core Mandate: Patient Safety and Data-Driven Excellence

Upon accepting the presidency, Dr. Damitz outlined a clear, ambitious vision for her one-year term. Central to her platform is a relentless focus on patient safety as the primary North Star for all surgical and administrative decision-making.

"I am deeply honored to lead the American Society of Plastic Surgeons and represent our dedicated members worldwide," Dr. Damitz remarked during the inaugural address. "As plastic surgeons, our responsibility extends far beyond the operating room. Patient safety must guide every decision we make, from clinical education to surgical innovation. I look forward to supporting the work of board-certified plastic surgeons and reinforcing our specialty’s leadership in delivering exceptional patient outcomes."

Dr. Damitz’s agenda is explicitly structured around the integration of quality metrics and outcomes-based data. By leveraging real-world evidence, she aims to foster a culture of heightened accountability across the specialty. Her objective is to ensure that plastic surgery remains a gold standard in medical care, where procedures are not only aesthetically successful but scientifically validated and ethically performed.


Chronology: A Career Built on Advocacy and Clinical Mastery

To understand the weight of Dr. Damitz’s new role, one must look at the arc of her professional journey. Her ascent to the ASPS presidency is the culmination of over two decades of dedicated service to the organization and the broader surgical community.

Early Foundations and Training

Dr. Damitz’s path to leadership began at the Hahnemann University School of Medicine, where she earned her medical degree. She subsequently moved to the University of North Carolina at Chapel Hill, where she completed both her general surgery and plastic surgery residencies. Recognizing the need for specialized precision, she pursued advanced fellowships in plastic, breast, and aesthetic surgery, establishing the technical foundation that would later define her clinical career.

Professional Milestones

  • 2002: Dr. Damitz joins the American Society of Plastic Surgeons, beginning a lifelong commitment to the society’s mission.
  • Committee Leadership: She served three influential years as the chair of the ASPS Membership Committee, where she focused on cultivating the next generation of plastic surgeons and maintaining high standards for board certification.
  • Health Policy Advocacy: During her tenure as ASPS Board Vice President for Health Policy and Advocacy, Dr. Damitz became a national voice for patients. She was instrumental in efforts to modernize the Women’s Health and Cancer Rights Act (WHCRA), ensuring that patients undergoing mastectomy have legal access to reconstructive surgery.
  • Expansion of Coverage: Her advocacy has been instrumental in expanding insurance coverage for breast reconstruction and providing a voice for patients with congenital conditions who require complex surgical intervention.

Current Leadership

Today, she serves as the Chief of the Division of Plastic and Reconstructive Surgery and the Director of Aesthetic Surgery at the University of North Carolina School of Medicine. As a Professor of Surgery, she continues to mentor residents and fellows, bridging the gap between academic research and clinical practice.


Supporting Data: The Scope of the ASPS

The organization Dr. Damitz now leads is the definitive authority on plastic surgery, representing more than 11,000 board-certified surgeons. The ASPS plays a dual role: it is both a professional society for surgeons and a public-facing advocate for patient safety.

The significance of the ASPS presidency is underscored by the current scale of the plastic surgery industry. According to internal data and annual reports from the Society, the specialty has seen a massive surge in demand for both non-invasive and surgical procedures. In an era where digital influence and social media drive aesthetic trends, the ASPS has become an essential filter, providing science-based education to a public that is often bombarded by misinformation.

Dr. Damitz’s emphasis on "outcomes-based data" is a direct response to this environment. By utilizing the Plastic Surgery Procedural Statistics and the CORE (Clinical Outcomes Registry and Evaluation) system, the ASPS is uniquely positioned to track long-term results, complication rates, and patient satisfaction. Under Dr. Damitz, the Society is expected to increase its investment in these data infrastructures to better inform public policy and clinical standards.


Official Responses and Industry Impact

The announcement of Dr. Damitz’s presidency has been met with broad approval from peers and hospital administrators alike. Her colleagues describe her as a "unifying force" who possesses the rare ability to balance the technical demands of complex reconstructive surgery with the nuanced challenges of aesthetic practice.

"Dr. Damitz represents the best of our specialty," said a senior member of the ASPS Board. "Her experience in health policy is exactly what we need as we navigate legislative hurdles regarding patient access and the ongoing fight against ‘board-certification’ dilution by non-specialists."

In her own words, Dr. Damitz has highlighted the importance of "multidisciplinary initiatives." Her work in breast reconstruction, for instance, often requires collaboration with oncologists, radiologists, and physical therapists. She views the role of the plastic surgeon as a coordinator of comprehensive care rather than a siloed practitioner. This philosophy is expected to guide her interactions with other medical organizations during her term.


Implications: The Road Ahead for 2027

As Dr. Damitz begins her term, the implications for the specialty are profound. Her leadership will likely focus on three major pillars:

1. Modernizing Patient Access

Building on her history with the WHCRA, Dr. Damitz is expected to push for legislative reforms that protect patient access to reconstructive care. In a healthcare environment where insurance coverage for elective or semi-elective procedures is frequently challenged, her expertise in the intricacies of health policy will be a significant asset to the Society’s lobbying efforts in Washington, D.C.

2. Standardizing Quality and Safety

With the rise of "med-spas" and surgeons from other disciplines entering the aesthetic space, the ASPS is under pressure to protect the public. Dr. Damitz’s tenure will likely see a renewed focus on public awareness campaigns that distinguish the rigorous training of an ASPS board-certified surgeon from other practitioners. Her focus on "quality metrics" will provide the evidence base to prove that safety is higher in the hands of those who have undergone accredited training.

3. International Collaboration

Plastic surgery is a global language. As the leader of the world’s largest society, Dr. Damitz will oversee international partnerships that share surgical techniques and ethical guidelines. Her commitment to education ensures that the ASPS will continue to be the primary hub for disseminating breakthrough research, from microsurgical reconstruction to the latest advancements in regenerative medicine.

4. Innovation in the Operating Room

Dr. Damitz has consistently advocated for a "collaboration-first" approach to innovation. Whether it is integrating artificial intelligence into surgical planning or advancing the use of fat grafting in oncologic reconstruction, she aims to ensure that the ASPS remains at the cutting edge of surgical science.


Conclusion: A Legacy in the Making

Dr. Lynn A. Damitz assumes the ASPS presidency at a moment when the specialty of plastic surgery stands at a crossroads. The demand for surgical intervention has never been higher, nor has the need for rigorous oversight and ethical stewardship.

Through her extensive background in health policy, her clinical leadership at the University of North Carolina, and her long-standing commitment to the ASPS, Dr. Damitz is uniquely equipped to navigate these complexities. Her term promises to be defined by a focus on "outcomes that matter"—a philosophy that puts the patient’s long-term health and wellbeing at the forefront of every surgical, policy, and educational initiative.

As she leads the Society through the next year, the broader medical community will be watching closely. With her blend of academic rigor, clinical expertise, and political acumen, Dr. Damitz is not merely managing a professional organization; she is shaping the future of a specialty that transforms lives, restores function, and enhances the human experience. Through her stewardship, the American Society of Plastic Surgeons is set to reinforce its role as the global benchmark for excellence, ensuring that as plastic surgery evolves, its core commitment to the patient remains steadfast and uncompromised.

About the Author

Jia Lissa

Author

View All Posts

Post navigation

Previous: The RNAi Renaissance: How Gene-Silencing Tech Became Biotech’s Hottest Commodity
Next: The Intersection of GLP-1 Medications and Breast Cancer: Navigating the Emerging Science

Related Stories

leading-the-future-of-plastic-surgery-dr-lynn-a-damitz-assumes-presidency-of-the-asps-2
  • Breast Cancer Surgery and Reconstruction

Leading the Future of Plastic Surgery: Dr. Lynn A. Damitz Assumes Presidency of the ASPS

Basiran October 23, 2026
leading-the-future-of-plastic-surgery-dr-lynn-a-damitz-assumes-presidency-of-the-asps-1
  • Breast Cancer Surgery and Reconstruction

Leading the Future of Plastic Surgery: Dr. Lynn A. Damitz Assumes Presidency of the ASPS

Layla Zulfa October 23, 2026
a-new-era-of-excellence-dr-lynn-a-damitz-takes-the-helm-as-president-of-the-american-society-of-plastic-surgeons-1
  • Breast Cancer Surgery and Reconstruction

A New Era of Excellence: Dr. Lynn A. Damitz Takes the Helm as President of the American Society of Plastic Surgeons

Dwi Wanna October 22, 2026

Recent Posts

  • A New Battlefront Against Aggressive Breast Cancer: OU Researchers Uncover How Tumors Hijack Immune System to Grow Nerves
  • Influenza mortality in hospitalised patients affected by vaccination
  • Navigating the Intersection of GLP-1 Medications and Breast Cancer: An Evolving Landscape
  • The Dual Reality of October: Advocacy, Research, and the Fight Against Metastatic Breast Cancer
  • Breakthrough in Breast Cancer Survivorship: Nutritional Supplement Shows Promise in Combating ‘Chemo Brain’

Recent Comments

No comments to show.

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

a-new-battlefront-against-aggressive-breast-cancer-ou-researchers-uncover-how-tumors-hijack-immune-system-to-grow-nerves
  • Medical Research and Clinical Trials

A New Battlefront Against Aggressive Breast Cancer: OU Researchers Uncover How Tumors Hijack Immune System to Grow Nerves

Basiran October 23, 2026
influenza-mortality-in-hospitalised-patients-affected-by-vaccination
  • Medical Research and Clinical Trials

Influenza mortality in hospitalised patients affected by vaccination

Sagoh October 23, 2026
navigating-the-intersection-of-glp-1-medications-and-breast-cancer-an-evolving-landscape-1
  • Patient Advocacy and Support

Navigating the Intersection of GLP-1 Medications and Breast Cancer: An Evolving Landscape

Lina Irawan October 23, 2026
the-dual-reality-of-october-advocacy-research-and-the-fight-against-metastatic-breast-cancer
  • Patient Advocacy and Support

The Dual Reality of October: Advocacy, Research, and the Fight Against Metastatic Breast Cancer

Raul Delapena Setiawan October 23, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.